Loading…

OK to use Google Analytics cookies? Declining changes nothing about how the site works. Privacy policy

Pricing About us Log in Create a free account

Directory

Every key opinion leader in the directory, every fact cited to its public source.

Showing 193–196 of 196 KOLs

Sort

Drug: Dalfampridine✕

Michael Lane, MD

Basic profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileNeurologyNeurologyWest · OR

—
publications: —
h-index

View profile →

Thai Nguyen, MD

Basic profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileNeurologyNeurologySouth Central · TX

—
publications: —
h-index: 31
companies

View profile →

Jennifer Graves, MD

Basic profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileNeurologyNeurologyWest · CA

—
publications: —
h-index: 1
NIH grant

View profile →

Aaron Miller, MD

Icahn School of Medicine at Mount Sinai

Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileNeurologyNeurologyNortheast · NY

—
publications: 16
h-index: 6
trials

View profile →

← PrevPage 9 of 9Next →

findmyKOL

The world’s largest open source directory of pharma KOLs.

KOLs by therapeutic area

Oncology
Respiratory
Cardiology
Neurology
Infectious Disease
Rheumatology/Immunology
Gastroenterology
Psychiatry
Endocrinology/Metabolic
Nephrology
Ophthalmology
Dermatology
Hematology
Rare/Genetic
Epidemiology
All therapeutic areas →

KOLs by region

Northeast
Midwest
West
Southeast
South Central
All regions →

About

Directory
Institutions
Companies
About us
Blog
Pricing
Methodology
Sources
How we verify
Contact

© 2026 findmyKOL